RESTORE-1
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm
- Stage
- klaar
- Medicine
- FlecIH-103
- Population
- Ritme
- Phase
- III
- First Patient In
- 15 August 2022
- Last Patient In
- 18 May 2023
- Last Patient Last Visit
- 18 May 2023
National Lead
prof. dr. M. Rienstra
Study Director
dr. S. Eijsbouts
Cardioloog
Office Contact
